SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 176.01-0.2%Dec 31 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Beltropolis Boy who wrote (1082)7/13/1999 5:43:00 PM
From: Biomaven  Read Replies (1) of 1686
 
Copithorne also points out that these new drugs are not expected to have the same sales potential as Avonex.

So much for that analyst. <g> I don't know if Antova is going to be successful, but I do know that if it is, it will be a much bigger drug than Avonex. Ah well, maybe she was misquoted.

Boy, these guys can't even write a decent bearish article. (Not that I care for the bullish ones either, but the bearish ones should be so much easier to write.)

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News